Loading company…
Riskpilot
← Back to search
Sign in
Get full access
PROPER3 AS
AS
Active
Org 990282382
Neuberggata 1A, 0367 Oslo
Development of building projects · NACE 6812
Est. 2006
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
Equity ratio
-370443.8%
Financial strength
Net profit 2024
NOK 0
0 employees
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK 0
—
Net profit
NOK 0
—
Total assets
NOK 365
+0%
Equity
NOK -1,4M
+0%
Employees
0
—
Company information
Legal name
PROPER3 AS
Org number
990282382
Legal form
Aksjeselskap
NACE code
6812 · Development of building projects
Founded
18. september 2006
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder hver for seg.
Company purpose
Eiendomsutvikling i øst-europa med hovedfokus på utleievirksomhet.
Contact
Address
Neuberggata 1A, 0367 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Development of building projects
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−2
0
0
0
0
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−2
0
0
0
0
Net financials
0
0
0
0
0
Profit before tax
−2
0
0
0
0
Tax
−0
−0
−0
−0
−0
Net profit
−2
0
0
0
0
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
0
0
0
0
0
Equity
−1 352
−1 352
−1 352
−1 352
−1 352
Long-term debt
1 173
1 173
1 173
75
75
Short-term debt
180
180
180
1 277
1 277
Total debt
1 352
1 352
1 352
1 352
1 352
Financial ratios
5-year trend
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
2020
2024
Equity ratio
-370443.8%
This company
38.2%
Market median
-969848% vs market
2020
2024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
2020
2024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
ES
Erich Solberg
Deputy Member
Deputy Member
2006
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
EH
Espen Hygen Daae
Chairman
2006
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Biotech Invest As
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Biotech Invest As
PROPER3 AS
(this company)
Board network connections
Board members of PROPER3 AS also hold positions in
0
other companies.
Person
Role here
Other companies
Erich Solberg
Deputy Member
0 companies
Espen Hygen Daae
Chairman
0 companies